TPD52L2 and metastatic malignant neoplasm in the lymph nodes: Furthermore, higher TPD52L2 expression was significantly predictive of worse clinical outcome in lymph node-positive patients with BLBC, indicating a potential relationship between TPD52L2 and malignancies with lymph node metastasis.